All lobbying filings
King & Spalding LLP
King & Spalding LLP filed a Q1 report for Atara Biotherapeutics, Inc. on April 21, 2025, reporting no lobbying activity.
Lobbying for Atara Biotherapeutics, Inc. · Biotechnology company
Filing · LD-2 quarterly report
Q1 reportNo activity
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
California
Lobbying activity
0
No itemized activity in this filing.